Finerenone: A Novel Drug Discovery for the Treatment of Chronic Kidney Disease.

Published in: Current drug discovery technologies (2024)

The present review covers the complete picture of ADME properties, bioanalytical techniques, clinical trials, toxicity, and possible avenues in this arena. Finerenone is effective compared to other mineralocorticoid receptor-like spironolactone and eplerenone, for the treatment of chronic kidney disease.

Keyphrases

chronic kidney disease
drug discovery
clinical trial
end stage renal disease
oxidative stress
combination therapy
peritoneal dialysis
open label
double blind
placebo controlled